Enzyme Stabilizer class drugs

2 results
CoTherix, Inc.
Usage: Miglustat is indicated as monotherapy for adult patients with mild to moderate type 1 Gaucher disease when enzyme replacement therapy is not an option due to allergy, hypersensitivity, or poor venous access.
Actelion Pharmaceuticals US, Inc.
Usage: ZAVESCA is indicated as a standalone treatment for adult patients with mild to moderate type 1 Gaucher disease when enzyme replacement therapy is not viable due to factors like allergy, hypersensitivity, or inadequate venous access.